Effect of health insurance on direct hospitalisation costs for in-patients with ischaemic stroke in ChinaMa Yong A B , Xiong Xianjun B , Li Jinghu B and Fang Yunyun A C
A School of Management, Beijing University of Chinese Medicine, No. 11, Bei San Huan Dong Lu, Chaoyang District, China. Email: email@example.com
C Corresponding author. Email: firstname.lastname@example.org
Australian Health Review 42(1) 39-44 https://doi.org/10.1071/AH16056
Submitted: 16 September 2016 Accepted: 15 November 2016 Published: 7 March 2017
Objectives The aim of the present study was to determine the direct medical costs of hospitalisations for ischaemic stroke (IS) in-patients with different types of health insurance in China and to analyse the demographic characteristics of hospitalised patients, based on data supplied by the China Health Insurance Research Association (CHIRA).
Methods A nationwide and cross-sectional sample of IS in-patients with International Classifications of Diseases 10th Revision (ICD-10) Code I63 who were ensured under either the Basic Medical Insurance Scheme for Employees (BMISE) or the Basic Medical Insurance Scheme for Urban Residents (BMISUR) was extracted from the CHIRA claims database. A retrospective analysis was used with regard to patient demographics, total hospital charges and costs.
Results Of the 49 588 hospitalised patients who had been diagnosed with IS in the CHIRA claims database, 28 850 (58.2%) were men (mean age 67.34 years) and 20 738 (41.8%) were women (mean age 69.75 years). Of all patients, 40 347 (81.4%) were insured by the BMISE, whereas 8724 (17.6%) were insured by the BMISUR; the mean age of these groups was 68.55 and 67.62 years respectively. For BMISE-insured in-patients, the cost per hospitalisation was RMB10 131 (95% confidence interval (CI) 10 014–10 258), the cost per hospital day was RMB787 (95% CI 766–808), the out-of-pocket costs per patient were RMB2346 (95% CI 2303–2388) and the reimbursement rate was 74.61% (95% CI 74.48–74.73%). For BMISUR-insured in-patients the cost per hospitalisation was RMB7662 (95% CI 7473–7852), the cost per hospital day was RMB744 (95% CI 706–781), the out-of-pocket costs per patient were RMB3356 (95% CI 3258–3454) and the reimbursement rate was 56.46% (95% CI 56.08–56.84%).
Conclusions Costs per hospitalisation, costs per hospital day and the reimbursement rate were higher for BMISE- than BMISUR-insured in-patients, but BMISE-insured patients had lower out-of-pocket costs. The financial burden was higher for BMISUR- than BMISE-insured in-patients. For BMISUR-insured in-patients, the out-of-pocket payment was 43.54% of total expenses, which means the government should increase the financial investment, raise reimbursement rates and set up differential reimbursements to meet the health needs of in-patients with different income levels.
What is known about the topic? Cardiovascular and cerebrovascular diseases are major non-communicable diseases affecting the health of the Chinese population. The China Health Statistics Yearbook (2013) reported that across all in-patients, 195 million (5.82%) had been discharged with a diagnosis of cerebrovascular disease. Of these, 118 million had IS, accounting for 60.51% of all in-patients with cerebrovascular disease and 54.97% of hospitalisation costs for all cerebrovascular disease in-patients. After the two basic insurance systems, namely the BMISE and BMISUR, had been established, the out-of-pocket expenses for patients were reduced. However, to date there have been no studies investigating how the different types of health insurance (i.e. the BMISE and the BMISUR) affected the costs of treatment of IS in-patients in China.
What does this paper add? This paper reports the direct costs for patients diagnosed with IS based on data supplied by the CHIRA. Direct hospitalisation costs depending on the type of insurance cover, age and gender were also evaluated.
What are the implications for practitioners? The present study found that the personal financial burden of disease treatment was higher for in-patients insured under the BMISUR than BMISE. For in-patients insured under the BMISUR, the out-of-pocket payment was 43.54% of total expenses, which means the government should increase the financial investment, raise reimbursement rates and set up differential reimbursement rates to meet the health needs of patients with different incomes.
Additional keywords: ischaemic stroke, in-patients, health insurance, direct hospitalization costs.
References World Health Organization (WHO). Non-communicable diseases country profiles, 2014. Available at: http://www.who.int/nmh/publications/ncd_profiles2014/en/. [verified 30 January 2016].
 World Health Organization (WHO). Global status report on non-communicable diseases, 2014. Available at: http://www.who.int/nmh/publications/ncd-status-report-2014/en/. [verified 30 January 2016].
 Ministry of Health of the People’s Republic of China. China health statistics yearbook, 2013. Beijing: Peking Union Medical College Press; 2013.
 Li W, Lu M, Feng SJ, Li WZ, Wu B, Fang Y. Clinical characteristics and long-term prognosis of patients with ischaemic and hemorrhagic stroke. Chin Med J (Engl) 2008; 88 892–7.
 Zhang LF, Yuang J, Hong Z, Yuan GG, Zhou F, Zhao LC. Proportion of different subtypes of stroke in China. Stroke 2004; 35 24–5.
 Jiang B, Wang W, Chen HL, Hong Z, Yang QD, Wu SP, Du XL, Bao QJ. Incidence and trends of stroke and its subtypes in China, results from three large cities. Stroke 2006; 37 63–5.
| Incidence and trends of stroke and its subtypes in China, results from three large cities.CrossRef |
 Wang YL, Wu D, Wang YJ. Survey on acute cerebrovascular events care in China. Stroke 2006; 2 56–57.
 Zhao D, Liu J, Wang W, Zeng ZC, Ch J, Liu J. Epidemiological transition of stroke in China, twenty-one-year observational study from the Sino-MONICA-Beijing project. Stroke 2008; 39 1668–74.
| Epidemiological transition of stroke in China, twenty-one-year observational study from the Sino-MONICA-Beijing project.CrossRef |
 Kiencke P, Daniel D, Grimm C, Rychlik R. Direct costs of Alzheimer’s disease in Germany. Eur J Health Econ 2011; 12 533–9.
| Direct costs of Alzheimer’s disease in Germany.CrossRef |
 Xia L, Li JH, Zhao K, Wu HY. Incidence and in-hospital mortality of acute aortic dissection in China: analysis of China Health Insurance Research (CHIRA) data 2011. J Geriatr Cardiol 2015; 12 502–6.
 Yao XY, Lin Y, Geng JL. An analysis of risk factors for ischaemic stroke of different age and gender. Chin J Intern Med 2012; 51 630–3.
 Li LC. The cost of in-patients with stroke in tertiary medical institutes in Tianjin. Master’s Thesis, TianJin Medical University, TianJin. 2013.
 Heeley E, Anderson CS, Huang YI, Jan S, Li Y, Liu M, Sun J, Xu E, Wu Y, Yang Q, Zhang J, Zhang S, Wang J. Role of health insurance in averting economic hardship infamilies after acute stroke in China. Stroke 2009; 40 2149–56.
| Role of health insurance in averting economic hardship infamilies after acute stroke in China.CrossRef |
 Rojas JI, Zurrú MC, Romano M, Patrucco L, Cristiano E. Acute ischaemic stroke and transient ischaemic attack in the very old-risk factor profile and stroke subtype between patients older than 80 years and patients aged less than 80 years. Eur J Neurol 2007; 14 895–9.
| Acute ischaemic stroke and transient ischaemic attack in the very old-risk factor profile and stroke subtype between patients older than 80 years and patients aged less than 80 years.CrossRef | 1:STN:280:DC%2BD2svksVegtA%3D%3D&md5=e3af51e0a32e9667dfdc94adc3db3545CAS |
 Wang DR, Hao ZL, Tao WD, Kong FY, Zhang SH, Wu B, Liu M. Acute ischaemic stroke in the very elderly Chinese: risk factors, hospital management and one-year outcome. Clin Neurol Neurosurg 2011; 113 442–6.
| Acute ischaemic stroke in the very elderly Chinese: risk factors, hospital management and one-year outcome.CrossRef |
 Yuan SS, Clas R, Meng QY. Hospitalization expenditure among cerebral infarction patients with New Cooperative Medical Scheme, 2007–2010. Chin J Publ Health 2012; 28 163–9.
 The Ministry of Human Resources and Social Security of the People’s Republic of China (MOHRSS). The national operation analysis report of medical insurance andmaternity insurance, 2011–2013. Beijing: MOHRSS; 2013.